Clinical trials
Imaging clinical trials
Below are recruiting imaging clinical trials, each written for real people, not researchers. We’re tracking 2,164 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07050550Recruiting
PET imaging test for people with liver injury
This study tests a new PET imaging agent called ¹⁸F-DFA to see if it can measure liver damage and liver failure. It may help doctors better understand your liver condition using a specialized scan.
Hangzhou, ZhejiangAges 18–80 - NCT07044713Recruiting
Fun activities for kids during blood tests
This trial tests if hand puppets, coloring books, or watching images can help children ages 3-6 feel less scared during blood draws. It's for healthy kids who need blood taken once.
Kilis, CentralAges 3–6 - NCT07053982Recruiting
New scan to find endometriosis spots
This trial tests a new type of PET/CT scan that uses a special tracer to find endometriosis lesions. It may help surgeons see exactly where the disease is, which could lead to more complete treatment.
ToulouseAges 18 years+ - NCT07050186RecruitingPhase 2
Cemiplimab for advanced NUT carcinoma
This trial tests a drug called cemiplimab for people with NUT carcinoma that has spread or cannot be removed. The drug aims to shrink tumors or slow their growth.
Chicago, IllinoisAges 18 years+ - NCT06389019Recruiting
Using AI to predict bladder cancer outcomes from scans and tissue
This study uses a computer program to analyze your CT scans and tumor tissue slides to better predict how your bladder cancer will behave. It may help doctors give you more personalized care.
Chongqing, Chongqing MunicipalityAges Any age - NCT07042295RecruitingPhase 2
Amivantamab or Cetuximab for Skin Cancer in People with Weakened Immune Systems
This trial tests two drugs, amivantamab with hyaluronidase or cetuximab, in people with weakened immune systems who have advanced skin cancer (squamous cell carcinoma). The goal is to see if these treatments can help shrink or control the cancer.
Birmingham, AlabamaAges 18 years+ - NCT07036770Recruiting
Heart artery check with new CT and camera inside arteries
This trial tests a new CT scanner (photon-counting CT) combined with a tiny camera inside the heart arteries to better see blockages. It's for people with chest pain or silent ischemia, but not for those having a big heart attack (STEMI) or with unstable conditions.
LeuvenAges 18 years+ - NCT07042919RecruitingPhase 1/Phase 2
Zanzalintinib for advanced liver cancer after prior treatment
This trial tests a new drug called zanzalintinib for people with advanced liver cancer (HCC) that can't be treated with surgery. You may join if your cancer has gotten worse after at least one prior treatment, or you couldn't tolerate that treatment.
Chicago, IllinoisAges 18 years+ - NCT07040449Recruiting
Stress and pleasure study for young teens
This study looks at how stress affects mood and the brain in teenagers aged 13 to 15. It involves brain scans and other tests to better understand teen mental health.
Chapel Hill, North CarolinaAges 13–15 - NCT07039825Recruiting
AAA CT scan registry study
This study collects information from people who have an abdominal aortic aneurysm and have had a special CT scan called CT angiography. Researchers want to learn more about this condition to help improve future care.
ShanghaiAges 18 years+ - NCT06995183Recruiting
Heart CT scan for relatives with high or low Lp(a)
This study uses a heart CT scan to look for early signs of heart disease in first-degree relatives of people with high or low Lp(a). It aims to find hidden risks before symptoms start.
Amsterdam, North HollandAges 50 years+ - NCT07027839RecruitingPhase 1
Alcohol effects on brain imaging for phosphodiesterase
This study uses PET scans to see how alcohol affects a protein in the brain called PDE4B. It may help explain how alcohol works in the body.
Bethesda, MarylandAges 21–70 - NCT06956144Recruiting
CAIX-targeted PET scan for kidney cancer
This trial uses a special PET scan that targets a protein (CAIX) often found in kidney cancer cells. It helps doctors see the cancer more clearly, which may guide better treatment decisions.
XiamenAges 18–74 - NCT07033364Recruiting
Liver function study after radiation treatment for metastases
This trial studies how well the liver works after stereotactic body radiation therapy (SBRT) for cancer that spread to the liver. If you had this specific type of radiation in three large doses, you may help researchers learn more about liver recovery.
AmsterdamAges 18 years+ - NCT07030205Recruiting
Brain imaging study for women with osteoporosis
This study uses brain scans (MRI) to look at how the brain might be linked to bone health in women with osteoporosis. It compares women with osteoporosis to healthy women of the same age.
Clermont-FerrandAges 50 years+ - NCT07033169Recruiting
Skin image tool to help doctors diagnose
This trial tests a new skin image reference tool that helps dermatologists diagnose skin conditions. You and your doctor will take photos of your skin and use the tool to compare with reference images.
Winston-Salem, North CarolinaAges 10 years+ - NCT07025226RecruitingEarly Phase 1
Combination drugs and vaccine for glioma with remaining tumor
This trial tests a combination of several drugs and a vaccine to see if they can help treat glioma that has not gone away with previous treatment. It is for people whose tumors have certain gene changes and who still have some tumor remaining after standard therapy.
Rochester, MinnesotaAges 18 years+ - NCT07023848Enrolling by invitationEarly Phase 1
Imaging study for HER2-positive cancers using a special tracer
This study uses a radioactive tracer to take pictures of tumors that have a protein called HER2. It may help doctors see where the cancer is in your body and could guide future treatment decisions.
Wuxi, JiangsuAges 18–75 - NCT07031336Recruiting
Photon-counting CT for better lung scans
This trial is testing a new type of CT scanner (photon-counting CT) for chest imaging. If you are already in the Duke-COPDGene study, you may be invited to also get this special scan to see if it gives clearer pictures of your lungs.
Durham, North CarolinaAges Any age - NCT07033923Recruiting
Brain study of mood changes in depression and bipolar disorder
This study uses a mobile app and brain scans to understand day-to-day mood changes in people with depression or bipolar disorder. It may help doctors learn how to better predict and treat these conditions.
Paris, ParisAges 18 years+ - NCT07025369RecruitingPhase 2
Hormone pill before PSMA scan for high-risk prostate cancer
This trial tests if giving a short-term hormone pill (relugolix) before a special PSMA PET/CT scan makes the scan clearer for men with high-risk prostate cancer. It may help doctors better see where the cancer is.
Scottsdale, ArizonaAges 18 years+ - NCT06994949RecruitingPhase 1
CSF flow study for babies with hemorrhagic hydrocephalus
This trial looks at how fluid moves in the brain of premature babies with hydrocephalus after bleeding. It uses special imaging to see if the fluid is flowing properly, which could help guide treatment.
Houston, TexasAges Up to 6 months - NCT07020117RecruitingPhase 1
Study of AKY-1189 for advanced solid tumors
This trial tests a new radioactive drug, AKY-1189, for people with solid tumors that have spread or cannot be removed. It may help if other treatments have stopped working.
Duarte, CaliforniaAges 18 years+ - NCT07020858Recruiting
FAPI imaging for heart attack risk in blocked arteries
This trial tests whether a special scan called FAPI-PET can predict heart problems in people with a chronic total occlusion (a completely blocked heart artery for at least 3 months). If you have this type of blockage and are planning to have a procedure to open it, this study may help guide your care.
Beijing, Beijing MunicipalityAges 18 years+
Hear when a new Imaging trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for imaging?
- Yes. Clin2 currently lists 2,164 recruiting imaging studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a imaging trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a imaging trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.